GDS2018 is now closed

We would like to thank the 160,000+ people from over 50 countries who took part in GDS2018 which was translated into 20 languages.

Across Europe, Scandinavia, North and South America, Australasia, the Balkans and the Middle East people gave of their time so generously. How much time did these amazing people spend making GDS2018 the largest drug survey ever conducted?

about 80,000 hours or
about 3,300 days or
about 475 weeks or
about 100 months
or more than 9 years

Pretty amazing!

All we can say is thank you so much to everyone of them and all our media partners and our international collaborators. GDS would not exist with them and you.

We will start analysing the data and preparing reports next week. We expect the global media release of our GDS2018 Key Findings Report to be released in May 2018. As soon as we have a fixed launch date we will let you know.

Have a safe, healthy and happy 2018.

Thank you
Professor Adam R Winstock on behalf of The Global Drug Survey Core Research Team
Jan 2018

Each year, GDS consults more than 100,000 people around the world on the way they use drugs. We do this to get to the heart of how, where, when, why and what drugs are being taken. By discussing the findings we aim to make drug use safer, regardless of the legal status of the drug.

Share your story with us and help change the conversation. Because your experience matters.

GDS: the world’s biggest drug survey

GDS2018 – exploring losing your drug virginity, drug checking, dark net markets, new drugs, quitting cannabis, alcohol health warning labels, drug purchase, delivery and sharing, MDMA – pills or powders and what the perfect MDMA might look like, ketamine bladder GHB and lots more . . .

Launch GDS2018 2017 Findings
Global Drug Survey results

If you value our research, please help us continue our work by donating to GDS here

GDS 2017 — Key findings! 2017 Global Drug Survey shows UK drug purity leading to spike in A&E admissions

2017 Press Release

Latest from the blog

Quitting cannabis

Read more

Pizza vs. cocaine delivery

Read more

How we do things at GDS

Read more

Lost your drug virginity?

Read more

Alcohol health warning labels, what are they good for?

Read more

New drugs on the block

Read more
Our media partners help spread the word worldwide these include...

See our full list of media partners

Why use GDS?

GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country.

GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools, designed and analysed by leading experts in the fields of epidemiology, addiction, criminology, toxicology and sociology GDS has access to drug use data from over 500,000 people from over 50 countries.

The GDS sampling frame allows you to effectively compare population segments - young, old, males, females, gay, straight, clubbers, thin people, obese people, vegetarians, those with a current psychiatric symptoms and diagnoses, students, northerners, southerners. GDS helps you better understand the quantitative dynamics of personal decision-making about drug use, detects regional differences in patterns of drug use and related harm, and informs novel interventions.

GDS creates beautiful data reports, digital health assessment tools and free harm reduction resources that aim to make drug use safer regardless of the legal status of the drug GDS reaches hidden, sentinel and hard to reach populations and puts you on top of emerging drug trends in your country and major cities.

Learn more about GDS

Download our PDF brochure

Online resource

Drinks Meter

The best drinking app and screening tool in the world – use in your region / service now.

Learn more

Latest tweets

20 April 2018

RT @acciontecnica: “The media needs drug-related problems” “los medios necesitan problemas relacionados con las drogas” @drcarlhart en #Sem…

19 April 2018

RT @cuppawithK: You can watch the @ScotParl debate on safer injecting facilities via this link from 2:30pm

19 April 2018

RT @MAPS: On this day 75 years ago, Dr. #AlbertHofmann became the first person to intentionally experience the #psychedelic effects of #LSD…